12/09/2024
5:22 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Verrica Pharmaceuticals (Subject)
| Form SC 13G/A | |
12/09/2024
4:17 PM | Verrica Pharmaceuticals (Issuer)
Zawitz David (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/09/2024
4:18 PM | Verrica Pharmaceuticals (Issuer)
Zawitz David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
3:55 PM | Verrica Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/21/2024
3:53 PM | Verrica Pharmaceuticals (Filer)
| Form 424B5 | |
11/20/2024
4:06 PM | Verrica Pharmaceuticals (Filer)
| Form 424B5 | |
11/20/2024
4:08 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
8:32 AM | Avoro Capital Advisors LLC (Filed by)
Verrica Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/06/2024
7:59 PM | Rieger Jayson (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/06/2024
8:02 PM | Rieger Jayson (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
8:03 PM | Kirby John J. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
|
11/06/2024
8:04 PM | Kirby John J. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
4:11 PM | Verrica Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/04/2024
3:17 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/11/2024
3:15 PM | Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:16 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/01/2024
3:37 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2024
3:15 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
3:15 PM | Manning Paul B (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2024
3:16 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/27/2024
3:50 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/26/2024
3:45 PM | Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
3:35 PM | Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
2:31 PM | Verrica Pharmaceuticals (Subject)
White Ted (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
2:17 PM | Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
2:08 PM | Kohler Terry (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/14/2024
6:56 AM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
7:07 AM | Verrica Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/23/2024
5:10 PM | Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
5:11 PM | Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
5:12 PM | Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/23/2024
5:13 PM | Verrica Pharmaceuticals (Issuer)
White Ted (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/22/2024
2:51 PM | Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2024
2:55 PM | Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2024
2:47 PM | Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
3:18 PM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
6:45 AM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
3:31 PM | Verrica Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
05/13/2024
7:01 AM | Verrica Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/13/2024
6:46 AM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2024
6:35 AM | Verrica Pharmaceuticals (Filer)
| Form DEFA14A | |
Must-See: 5-Second Trump Prediction (Ad) President Trump's prediction is about to become a reality...
Opening a rare window of opportunity for you to accelerate your retirement during the first 100 days of his administration. Click here now to get the details because you must act before January 20th. |
04/19/2024
6:40 AM | Verrica Pharmaceuticals (Filer)
| Form ARS | |
04/19/2024
6:30 AM | Verrica Pharmaceuticals (Filer)
| Form DEF 14A | |
03/19/2024
3:31 PM | Verrica Pharmaceuticals (Issuer)
White Ted (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:31 PM | Bonaccorso Joe (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:31 PM | Kohler Terry (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:31 PM | Goldenberg Gary (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
3:31 PM | Hayes Christopher G. (Reporting)
Verrica Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
7:05 AM | Verrica Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/29/2024
6:45 AM | Verrica Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
3:47 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Verrica Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/14/2024
8:10 AM | Avoro Capital Advisors LLC (Filed by)
Verrica Pharmaceuticals (Subject)
| Form SC 13G | |
